Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women
Status:
Completed
Trial end date:
2009-01-21
Target enrollment:
Participant gender:
Summary
Open-label Phase IV trial of Letrozole 2,5mg po/day for 120 days prior to surgery for
patients with locally advanced breast in postmenopausal women expressing hormonal receptors (
ER and PR)